A2 BIOTHERAPEUTICS

a2-biotherapeutics-logo

A2 Biotherapeutics is an early-stage biotechnology company located in Southern California that develops novel medicines for serious illnesses. We utilize an advanced targeting technology platform to increase the effectiveness of the bodyโ€™s natural immune defenses.

#SimilarOrganizations #People #Financial #Website #More

A2 BIOTHERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science

Founded:
2018-01-01

Address:
Westlake Village, California, United States

Country:
United States

Website Url:
http://www.a2bio.com

Total Employee:
11+

Status:
Active

Total Funding:
128.5 M USD

Technology used in webpage:
SPF IPv6 Google Apps For Business Microsoft Azure DNS Google DMARC Google DNS Google Domains Google Cloud DNS DNSSEC


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

celsius-therapeutics-logo

Celsius Therapeutics

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

immpact-bio-logo

ImmPACT Bio

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

Current Employees Featured

not_available_image

Han Xu
Han Xu Sr Director Technology @ A2 Biotherapeutics
Sr Director Technology
2018-01-01

madhavan-balachandran_image

Madhavan Balachandran
Madhavan Balachandran Independent Director @ A2 Biotherapeutics
Independent Director
2019-08-01

michelle-kreke_image

Michelle Kreke
Michelle Kreke Vice President, Head of Technical Operations @ A2 Biotherapeutics
Vice President, Head of Technical Operations
2021-02-01

david-lucas_image

David Lucas
David Lucas Vice President Operations @ A2 Biotherapeutics
Vice President Operations
2018-01-01

not_available_image

Agi Hamburger
Agi Hamburger Senior Director Drug Discovery @ A2 Biotherapeutics
Senior Director Drug Discovery
2018-01-01

alexander-kamb_image

Alexander Kamb
Alexander Kamb President and CSO @ A2 Biotherapeutics
President and CSO
2018-01-01

Founder


alexander-kamb_image

Alexander Kamb

Investors List

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series B - A2 Biotherapeutics

hartford-healthcare-endowment_image

Hartford HealthCare Endowment

Hartford HealthCare Endowment investment in Series B - A2 Biotherapeutics

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series B - A2 Biotherapeutics

uc-investments_image

UC Investments

UC Investments investment in Series B - A2 Biotherapeutics

euclidean-capital_image

Euclidean Capital

Euclidean Capital investment in Series B - A2 Biotherapeutics

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series B - A2 Biotherapeutics

the-column-group_image

The Column Group

The Column Group investment in Series B - A2 Biotherapeutics

vida-ventures_image

Vida Ventures

Vida Ventures investment in Series B - A2 Biotherapeutics

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series A - A2 Biotherapeutics

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series A - A2 Biotherapeutics

Official Site Inspections

http://www.a2bio.com Semrush global rank: 7.82 M Semrush visits lastest month: 436

  • Host name: 104.26.2.238
  • IP address: 104.26.2.238
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "A2 Biotherapeutics"

About Us - A2 Biotherapeutics

We are driven by a commitment to rigorous science and the urgency to bring cell therapies to cancer patients. Led by an experienced leadership team, equipped with versatile research and โ€ฆSee details»

A2 Biotherapeutics - Crunchbase Company Profile

A2 Biotherapeutics focuses on innovative T cell therapies that precisely distinguish between solid tumors and normal cells. The proprietary Tmodโ„ข platform integrates multiple signals to enhance treatment effectiveness while โ€ฆSee details»

Our Leadership Team - A2 Biotherapeutics

A2 Bio is well positioned to deliver on its development plans with a highly experienced executive team with proven track records in discovery, development, manufacturing and commercialization of oncology therapeutics across multiple โ€ฆSee details»

A2 Biotherapeutics Company Profile | Management and

Www.a2bio.com . A2 Biotherapeutics Profile and History ... A2 Biotherapeutics is a fully integrated discovery, development, and manufacturing organization that focuses on biotechnology and โ€ฆSee details»

A2 Biotherapeutics, Inc. | LinkedIn

A2 Biotherapeutics, Inc. Biotechnology Research Agoura Hills, CA 13,716 followers Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.See details»

A2 Biotherapeutics - Overview, News & Similar companies

View A2 Biotherapeutics (www.a2bio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much โ€ฆSee details»

A2 BIOTHERAPEUTICS, INC. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for A2 BIOTHERAPEUTICS, INC. of Agoura Hills, CA. Get the latest business insights from Dun & โ€ฆSee details»

A2 Biotherapeutics - Craft

A2 Biotherapeutics has 5 employees at their 1 location and $128.5 m in total funding,. See insights on A2 Biotherapeutics including office locations, competitors, revenue, financials, โ€ฆSee details»

A2 Biotherapeutics Inc. (A2 Bio) - life-sciences-usa.com

Jan 1, 2018 Advertisement. More documents for A2 Biotherapeutics Inc. (A2 Bio) [1] A2 Biotherapeutics, Inc..(3/25/24). "Press Release: A2 Bio Appoints James Robinson as New โ€ฆSee details»

A2 Biotherapeutics, Inc. Overview | SignalHire Company Profile

A2 Biotherapeutics, ... Employees Size. 100-200 employees. Specialties. Biotechnology, Immunotherapy, Oncology, Research, Target Identification, Cell Therapy ...See details»

A2 Biotherapeutics Closes $71.5M Series B To Begin Clinical โ€ฆ

Oct 6, 2020 A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing organization with more than 40 staff located in Agoura Hills, California. The โ€ฆSee details»

Investors - A2 Biotherapeutics

A2 Bio is backed by investors that include The Column Group, Samsara BioCapital, Vida Ventures, Nextech Invest, Casdin Capital, UC Investments (Office of the Chief Investment โ€ฆSee details»

A2 Biotherapeutics Closes $71.5M Series B to Begin ... - Business โ€ฆ

Oct 6, 2020 A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing organization with more than 40 staff located in Agoura Hills, California. ...See details»

A2 Biotherapeutics - Work in biotech

A2 Biotherapeutics is designing novel cell therapies to treat serious illnesses. Therapeutics to treat cancers depend on methods to distinguish tumors from normal cells. A2 Bio is using their โ€ฆSee details»

A2 Biotherapeutics Emerges From Stealth Mode With $57M Series โ€ฆ

Nov 5, 2019 AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics (www.a2bio.com), a biotechnology company developing innovative cell therapies for cancer patients, today โ€ฆSee details»

A2 Biotherapeutics Enters Into Collaboration Agreement With โ€ฆ

Dec 23, 2020 A2 Biotherapeutics, Inc. David Lucas Phone: (805) 719-6423 Email: [email protected] Release Summary A2 Biotherapeutics Enters Into Collaboration Agreement โ€ฆSee details»

A2 Biotherapeutics Partnerships

A2 Bio has a research collaboration with Merck for its first allogeneic program and an option for a second program. This is Merckโ€™s first partnership in the cell therapy area, and their decision to โ€ฆSee details»

First participants randomized in AskBio Phase II gene therapy

5 days ago Berlin, Germany, and Research Triangle Park, N.C., USA, January 14, 2025 โ€“ AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a โ€ฆSee details»

Our Science - A2 Biotherapeutics

Our approach exploits a common and irreversible loss of genetic material unique to tumor cells, called LOH. LOH occurs when a cell that is originally heterozygous at a gene locus loses one โ€ฆSee details»

Newsroom - A2 Biotherapeutics

Jan 9, 2025 Exciting things are happening at A2 Biotherapeutics. Here are the latest news about our company, products, and pipeline.See details»

linkstock.net © 2022. All rights reserved